Back to search

Article

Epigenetic profiles of response to transcranial magnetic stimulation in treatment resistant depression

2025-07-22

Abstract excerpt

<title>Abstract</title> <p> Background Transcranial magnetic stimulation (TMS) is an established treatment for major depressive disorder (MDD), yet response rates remain suboptimal and biomarkers predictive of treatment outcomes are currently lacking. Recently, DNA methylation (DNAm) has shown promise as an epigenetic predictor of antidepressant and electroconvulsive therapy treatment outcomes but no study to ou...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7a77e42c-01f5-5e8e-a5b9-dabdc1d1625c
DOI
10.21203/rs.3.rs-6882834/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Epigenetic profiles of response to transcranial magnetic stimulation in treatment resistant depressionDOI 10.21203/rs.3.rs-6882834/v1
Leveraging DNA Methylation to Predict Treatment Response in Major Depressive Disorder: A Critical ReviewSemantic proximity
Epigenome-Wide DNA Methylation in Unipolar Depression: Predictive Biomarker of Antidepressant Treatment Response?Semantic proximity
Epigenetic Signatures in Antidepressant Treatment Response: a Methylome-wide Association Study in the EMC TrialSemantic proximity
Dynamic Epigenetic Changes During Antidepressant Pharmacotherapy in Major Depressive DisorderSemantic proximity
A Genetic Profile of Refractory Individuals with Major Depressive Disorder and Their Responsiveness to Transcranial Magnetic StimulationSemantic proximity
Novel candidate genes for ECT response prediction—a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapySemantic proximity
Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication StudySemantic proximity
Methylome-wide change associated with response to electroconvulsive therapy in depressed patientsSemantic proximity
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive TherapySemantic proximity
A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping.Semantic proximity
Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response.Semantic proximity
DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?Semantic proximity
Select a neighboring publication to make it the new centre.